Apollomics, Inc.

Apollomics, Inc.verified

APLM

Price:

$14.745

Market Cap:

$16.27M

Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecule multiple tyrosine kinase inhibitor for liver cancer, breast cancer, and esophageal cancer; and APL-122, a tumor inhibitor candidate to treat cancers within the brain. The company was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated...[Read more]

Industry

Biotechnology

IPO Date

2021-11-26

Stock Exchange

NASDAQ

Ticker

APLM

The Enterprise Value as of December 2025 (TTM) for Apollomics, Inc. (APLM) is 7.47M

According to Apollomics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.47M. This represents a change of -91.97% compared to the average of 93.00M of the last 4 quarters.

Apollomics, Inc. (APLM) Historical Enterprise Value (quarterly & annually)

How has APLM Enterprise Value performed in the past?

The mean historical Enterprise Value of Apollomics, Inc. over the last ten years is 569.21M. The current 7.47M Enterprise Value has changed 31.21% with respect to the historical average. Over the past ten years (40 quarters), APLM's Enterprise Value was at its highest in in the December 2020 quarter at 3.73B. The Enterprise Value was at its lowest in in the December 2021 quarter at -45704000.00.

Quarterly (TTM)
Annual

Average

569.21M

Median

773.16M

Minimum

233.12K

Maximum

956.76M

Apollomics, Inc. (APLM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Apollomics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 11.78%

Maximum Annual Enterprise Value = 956.76M

Minimum Annual Increase = -99.47%

Minimum Annual Enterprise Value = 233.12K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024233.12K-99.47%
202344.40M-94.88%
2022867.52M6.29%
2021816.18M11.78%
2020730.14M-23.69%

Apollomics, Inc. (APLM) Average Enterprise Value

How has APLM Enterprise Value performed in the past?

The current Enterprise Value of Apollomics, Inc. (APLM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

304.05M

5-year avg

491.69M

10-year avg

569.21M

Apollomics, Inc. (APLM) Enterprise Value vs. Peers

How is APLM’s Enterprise Value compared to its peers?

Apollomics, Inc.’s Enterprise Value is greater than SeaStar Medical Holding Corporation (-3752301.00), greater than Moleculin Biotech, Inc. (3.01M), greater than Athira Pharma, Inc. (-4600560.00), less than Lunai Bioworks Inc. (33.22M), less than Tharimmune, Inc. (84.57M), less than BioLineRx Ltd. (19.48M), less than Adaptimmune Therapeutics plc (97.78M), less than Leap Therapeutics, Inc. (53.86M), greater than GeoVax Labs, Inc. (4.72M), greater than Adlai Nortye Ltd. (3.81M),

Build a custom stock screener for Apollomics, Inc. (APLM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apollomics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Apollomics, Inc. (APLM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Apollomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Apollomics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Apollomics, Inc. (APLM)?

What is the 3-year average Enterprise Value for Apollomics, Inc. (APLM)?

What is the 5-year average Enterprise Value for Apollomics, Inc. (APLM)?

How does the current Enterprise Value for Apollomics, Inc. (APLM) compare to its historical average?